Design Optimization of Piezocomposites Using a Homogenization Model: From Analytical Model to Experimentation.

In the process of activating non-conductive smart-structures using piezoelectric patches, one possible method is to add a conductive layer to ensure electrical contact of both electrodes of the ceramic. Therefore, depending on the stiffness and the thickness of this layer, changes in the overall piezoelectric properties lead to a loss in the electromechanical coupling that can be implemented. The purpose of this work is to study the impact of this added electrode layer depending on its thickness. A model of the effect of this layer on the piezoelectrical coefficients has been derived from the previous approach of Hashimoto and Yamagushi and successfully compared to experimental data. This global model computes the variation of all the piezoelectric coefficients, and more precisely of k31 or d31 for various brass electrode volumes relative to the ceramic volume. A decrease in the lateral electromechanical coupling factor k31 was observed and quantified. NAVY II PZT piezoelectric transducers were characterized using IEEE standard methods, with brass electrode thicknesses ranging from 50 to 400 microns. The model fits very well as shown by the results, leading to good expectations for the use of this design approach for actuators or sensors embedded in smart-structures.

An Oral FMT Capsule as Efficient as an Enema for Microbiota Reconstruction Following Disruption by Antibiotics, as Assessed in an In Vitro Human Gut Model.

Fecal microbiota transplantation (FMT) is an innovative therapy already used in humans to treat Clostridioides difficile infections associated with massive use of antibiotics. Clinical studies are obviously the gold standard to evaluate FMT efficiency but remain limited by regulatory, ethics, and cost constraints. In the present study, an in vitro model of the human colon reproducing medically relevant perturbation of the colonic ecosystem by antibiotherapy was used to compare the efficiency of traditional FMT enema formulations and a new oral capsule in restoring gut microbiota composition and activity. Loss of microbial diversity, shift in bacterial populations, and sharp decrease in fermentation activities induced in vivo by antibiotherapy were efficiently reproduced in the in vitro model, while capturing inter-individual variability of gut microbiome. Oral capsule was as efficient as enema to decrease the number of disturbed days and bacterial load had no effect on enema performance. This study shows the relevance of human colon models as an alternative approach to in vivo assays during preclinical studies for evaluating FMT efficiency. The potential of this in vitro approach could be extended to FMT testing in the management of many digestive or extra-intestinal pathologies where gut microbial dysbiosis has been evidenced such as inflammatory bowel diseases, obesity or cancers.